CLINICAL_TRIALS
trial_result
· 2024-12-18
Clinical Trial Update: Dupilumab in CRSsNP [Phase 3]
Summary
Phase 3 trial of dupilumab in chronic rhinosinusitis without nasal polyps has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis Without Nasal Polyps, Sinusitis | Phase 3 | Status: COMPLETED | Results posted: 2024-12-18